• Nenhum resultado encontrado

[PDF] Top 20 Alpha-synuclein phosphorylation role on Parkinson's disease

Has 10000 "Alpha-synuclein phosphorylation role on Parkinson's disease" found on our website. Below are the top 20 most common "Alpha-synuclein phosphorylation role on Parkinson's disease".

Alpha-synuclein phosphorylation role on Parkinson's disease

Alpha-synuclein phosphorylation role on Parkinson's disease

... the role of phosphorylation at S129 on αSyn dynamics (S129A formed more inclusions and sooner than the WT protein) and showed the modulation of non-phosphorytable αSyn toxicity by ER-Golgi ... See full document

128

Alpha-synuclein phosphorylation role on Parkinson’s disease

Alpha-synuclein phosphorylation role on Parkinson’s disease

... A doença de Parkinson (DP) é uma doença neurodegenerativa caracterizada pela presença de inclusões proteicas designadas por corpos de Lewy (LB). Os LB são agregados intracelulares que se formam nos neurónios ... See full document

52

SMG1 identified as a regulator of Parkinson's disease-associated alpha-synuclein through siRNA screening.

SMG1 identified as a regulator of Parkinson's disease-associated alpha-synuclein through siRNA screening.

... hyperphosphorylated on serine 129 (S129) compared to the unaggregated form of the ...S129 phosphorylation is an early event in a-synuclein dysfunction and ...critical phosphorylation event may ... See full document

12

The role of alpha-synuclein in melanin synthesis in melanoma and dopaminergic neuronal cells.

The role of alpha-synuclein in melanin synthesis in melanoma and dopaminergic neuronal cells.

... Parkinson’s disease (PD) and melanoma has been established by a large number of epidemiological ...for alpha- Synuclein (a-Syn) that expresses not only in brain, but also in skin as well as in ... See full document

8

The role of alpha-synuclein oligomerization and aggregation in cellular and animal models of Parkinson's disease.

The role of alpha-synuclein oligomerization and aggregation in cellular and animal models of Parkinson's disease.

... Parkinson’s disease (PD) is a common neurodegenerative disorder that is marked by the degeneration of dopaminergic neurons in the substantia nigra pars compacta (SNc) and the presence of Lewy bodies (LBs) ... See full document

14

Site-specific perturbations of alpha-synuclein fibril structure by the Parkinson's disease associated mutations A53T and E46K.

Site-specific perturbations of alpha-synuclein fibril structure by the Parkinson's disease associated mutations A53T and E46K.

... fluorescence under identical conditions to the preparation of the NMR samples. The A53T and E46K mutant proteins exhibited accelerated fibrillation kinetics relative to WT (Figure 1A), consistent with previous reports ... See full document

8

Low CSF levels of both α-synuclein and the α-synuclein cleaving enzyme neurosin in patients with synucleinopathy.

Low CSF levels of both α-synuclein and the α-synuclein cleaving enzyme neurosin in patients with synucleinopathy.

... Parkinson’s disease (PD) and dementia with Lewy bodies ...significant role of a-synuclein in the pathophysiology of Alzheimer’s disease ...a- synuclein concentrations were positively ... See full document

8

The effects of the novel A53E alpha- synuclein mutation on its oligomerization and aggregation

The effects of the novel A53E alpha- synuclein mutation on its oligomerization and aggregation

... Parkinson’s disease (PD), the second most common neurodegenerative disorder after Alzheimer’s ...important role in these disorders, collectively known as ...impact on important cellular functions ... See full document

15

Systematic comparison of the effects of alpha-synuclein mutations on its oligomerization and aggregation.

Systematic comparison of the effects of alpha-synuclein mutations on its oligomerization and aggregation.

... of alpha-synuclein (ASYN) in Lewy bodies and Lewy neurites is the typical pathological hallmark of Parkinson’s disease (PD) and other ...central role in the ...mutations on the ... See full document

18

Genetics of Parkinson’s Disease - A Clinical Perspective

Genetics of Parkinson’s Disease - A Clinical Perspective

... focus on genes with a Mendelian inheritance (Table 1), including alpha-synuclein gene (SNCA, PARK1/4), parkin gene (Parkin, PARK2), P-TEN-induced putative kinase 1 gene (PINK1, PARK6), Daisuke-Junko ... See full document

9

Naturally occurring alpha-synuclein autoantibodies in Parkinson's disease: sources of (error) variance in biomarker assays.

Naturally occurring alpha-synuclein autoantibodies in Parkinson's disease: sources of (error) variance in biomarker assays.

... depend on specific PD motor phenotypes ...efforts on redefinitions of diagnostic criteria of PD and formal PD subtype definitions [42] may allow for more specific investigations of biomarkers based ... See full document

16

Diagnostic validity of biomarkers in Parkinson’s Disease: systematic review and meta-analysis

Diagnostic validity of biomarkers in Parkinson’s Disease: systematic review and meta-analysis

... depending on the environment. Although the functional role of α-synuclein has not yet been established, its membrane-binding affinity and the presynaptic location of α-synuclein indicate a ... See full document

10

Nullity of GSTT1/GSTM1 related to pesticides is associatedwith Parkinson's disease

Nullity of GSTT1/GSTM1 related to pesticides is associatedwith Parkinson's disease

... Fatores genéticos e ambientais inluenciam a patogênese da doença de Parkinson (DP). Variantes genéticas das enzimas glutationa S-trans- ferases (GST) parecem estar envolvidas com a doença. Os objetivos ... See full document

6

The SARS Coronavirus 3a protein causes endoplasmic reticulum stress and induces ligand-independent downregulation of the type 1 interferon receptor.

The SARS Coronavirus 3a protein causes endoplasmic reticulum stress and induces ligand-independent downregulation of the type 1 interferon receptor.

... The hepatitis C virus (HCV) expresses viral proteins that cause ER stress [67], and HCV-induced UPR promotes IFNAR1 phosphorylation, ubiquitination and downregulation [31]. The vesicular stomatitis virus (VSV) ... See full document

10

Adiponectin Upregulates MiR-133a in Cardiac Hypertrophy through AMPK Activation and Reduced ERK1/2 Phosphorylation.

Adiponectin Upregulates MiR-133a in Cardiac Hypertrophy through AMPK Activation and Reduced ERK1/2 Phosphorylation.

... effect on miR-133a remains ...(AMPK) phosphorylation and inhibited ERK activa- ...APN on AMPK activation and miR- 133a, and the inhibitory effect on ERK phosphorylation were inhibited ... See full document

16

Dement. neuropsychol.  vol.2 número2

Dement. neuropsychol. vol.2 número2

... Resumo – Sintomas psiquiátricos e de comportamento são comuns em várias doenças neurodegenerativas, com perfis distintos que são úteis no diagnóstico e no acompanhamento destas doenças. O Inventário Compor- tamental de ... See full document

6

Functional and genetic analysis of alpha-synuclein and huntingtin in Drosophila melanogaster

Functional and genetic analysis of alpha-synuclein and huntingtin in Drosophila melanogaster

... each disease are determined by the region of the brain that degenerates (Table ...Parkinson’s disease (PD) and Huntington’s disease (HD) belong to this category, although they frequently show ... See full document

211

Study of structural and dynamic properties of alpha-synuclein

Study of structural and dynamic properties of alpha-synuclein

... -synuclein is a protein found in presynaptic nerve cells, and which the main purpose (if there is any) is still unknown. Rather, it might be possible that this protein is involved in many different functions in ... See full document

80

The Impact of Deep Brain Stimulation on the Quality of Life and Swallowing in Individuals with Parkinson ’s Disease

The Impact of Deep Brain Stimulation on the Quality of Life and Swallowing in Individuals with Parkinson ’s Disease

... studies on DBS claim that the surgery does not negatively affect swallowing, but there is still no evidence that it is an effective form of treatment for dysphagia in patients with ...DBS on dysphagia is ... See full document

5

Fabry disease - importance of screening in cornea verticillata: case report

Fabry disease - importance of screening in cornea verticillata: case report

... Treatment is composed of medications to alleviate symptoms as also disease-specific therapy to delay and prevent possible serious organ damage. Enzyme reposition therapy (ERT) provides the bio- logically ... See full document

2

Show all 10000 documents...

temas relacionados